In a double-blind, randomized and placebo-controlled trial, adjuvant allopurinol improved symptoms of mania in in-patients suffering from bipolar disorder / Leila Jahangard en European Neuropsychopharmacology, Año 2014 - Vol. 24 - No.8 (Agosto)

Público ISBD [artículo]  inEuropean Neuropsychopharmacology > Año 2014 - Vol. 24 - No.8 (Agosto) . - pp. 1210-1221 Título : In a double-blind, randomized and placebo-controlled trial, adjuvant allopurinol improved symptoms of mania in in-patients suffering from bipolar disorder Tipo de documento: texto impreso Autores: Leila Jahangard, Autor ; Sara Soroush, Autor ; Mohammad Haghighi, Autor Fecha de publicación: 2021 Artículo en la página: pp. 1210-1221 Idioma : Inglés (eng) Idioma original : Inglés (eng) Etiquetas: Alopurinol, Manía, Trastornos bipolares, Doble ciego, Ensayo controlado con placebo Resumen: Allopurinol is a drug used primarily to treat hyperuricemia. In patients suffering from acute mania, increased levels of uric acid are observed, and symptom improvements are associated with decreased levels of uric acid. Link: ./index.php?lvl=notice_display&id=26894 [artículo] In a double-blind, randomized and placebo-controlled trial, adjuvant allopurinol improved symptoms of mania in in-patients suffering from bipolar disorder [texto impreso] / Leila Jahangard, Autor ; Sara Soroush, Autor ; Mohammad Haghighi, Autor . - 2021 . - pp. 1210-1221. Idioma : Inglés (eng) Idioma original : Inglés (eng) in European Neuropsychopharmacology > Año 2014 - Vol. 24 - No.8 (Agosto) . - pp. 1210-1221 Etiquetas: Alopurinol, Manía, Trastornos bipolares, Doble ciego, Ensayo controlado con placebo Resumen: Allopurinol is a drug used primarily to treat hyperuricemia. In patients suffering from acute mania, increased levels of uric acid are observed, and symptom improvements are associated with decreased levels of uric acid. Link: ./index.php?lvl=notice_display&id=26894

---

1 (1 - 1 / 1) Por página: 25 50 100 200